Solvay is a multi-specialty chemical company, committed to developing chemistry that addresses key societal challenges. Solvay innovates and partners with customers in diverse global end markets. Its products and solutions are used in planes, cars, smart and medical devices, batteries, in mineral and oil extraction, among many other applications promoting sustainability. Its lightweighting materials enhance cleaner mobility, its formulations optimize the use of resources and its performance chemicals improve air and water quality. Solvay is headquartered in Brussels with around 27,000 employees in 58 countries. Net sales were € 10.9 billion in 2016, with 90% from activities where Solvay ranks among the world’s top 3 leaders. Solvay SA (SOLB.BE) is listed on Euronext Brussels and Paris (Bloomberg: SOLB.BB - Reuters: SOLB.BR) and in the United States its shares (SOLVY) are traded through a level-1 ADR program.
According to the Belgian transparency legislation in force (Law of May 2, 2007), BlackRock Inc. (55 East 52nd Street, New York, NY, 10055, U.S.A.) has notified Solvay SA that on November 8, 2017, the number of direct voting rights held by BlackRock Inc. crossed the 3% statutory threshold upward, totalling 3.35%. Together with the voting rights held through equivalent financial instruments, it detains 3.95% of the existing voting rights emitted by Solvay S.A.
The declarations by BlackRock Inc. are published in the Investor Relations Section of Solvay's website.